Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients with Atherosclerotic Cardiovascular Disease: Insights from the NCDR PINNACLE Registry Vittal Hejjaji @arnoldgehrke Saint Luke's Mid America Heart Institute #AHAJournals ahajrnls.org/43Clp7K

Patients w/ #CCD who were younger or had a high burden of angina derived ⬆️ symptomatic benefit from invasive management Models to predict a patient's 1-yr health status outcomes w/ different Tx strategies could be used to inform shared decision-making bit.ly/43VdLpt

🏥 Dive into patient-reported outcomes at the #NYValves2024 FDA Town Hall! Explore interpretation validity, incorporating PROs in endpoints, and the debate on placebo-controlled trials! 📊 @arnoldgehrke @javedbutler1 Harlan Krumholz Chetan Huded David J. Cohen, MD, MSc #CardioEd #CardioResearch

Just go with the flow in aortic stenosis (AS)? Get up to date in normal-flow low-gradient AS – definitions, diagnosis, points of error, and management strategies in the US and European guidelines. bit.ly/46CbbWo #JACCIMG Ahmed Elkaryoni @arnoldgehrke

🚀 Let's kick off the first late-breaking trials session at #TCT2024 in collaboration with NEJM! 🔍 EARLY TAVR 🔍 EVOLVED 🔍 TAVR UNLOAD Philippe Genereux Dr. Nicolas M Van Mieghem Jane Leopold MD @arnoldgehrke Tsuyoshi Kaneko Joann Lindenfeld @slittlemd #CardioX #CardioResearch

#TCT2024: Drs. @arnoldgehrke, RTHahnMD, Susheel Kodali, MD, David J. Cohen, MD, MSc, et al present secondary analyses from the #TRISCENDII pivotal trial with #simpub in #JACC They find that #TTVR for #vhdTR is assoc w/ sustained health status improvement at 1 yr bit.ly/3Ukv6En

Presenting results from TRISCEND II at #TCT2024, Suzanne V. Arnold (@arnoldgehrke), MD, provides insight on quality-of-life improvements for patients with severe tricuspid regurgitation who undergo transcatheter valve replacement. TCTMD

The best teams eat tapas together and celebrate #AHA24 🫶🏻🫀 Saint Luke's Mid America Heart Institute Saint Luke's Healthcare Institute for Innovations in Quality @arnoldgehrke Mohd Jawad Dr Fred Alexander Iribarne, MD Andrew J Sauer MD Nobuhiro Ikemura Len AHAMeetings AHA Science

Watch Now! 👉www. opci.live/journal-club/ The latest OPCI Journal Club features @arnoldgehrke on "Quality of Life after Transcatheter Tricuspid Valve Replacement: Results from the TRISCEND II Pivotal Trial." Joined by esteemed panelists David J. Cohen, MD, MSc Jaffar Khan and Drs. William

For patients with tricuspid regurgitation, the extent of disease appears to influence 1-year mortality following T-TEER, confirm new prospective European registry data. Philipp Lurz @arnoldgehrke tctmd.com/news/intermedi…

The #JACC Journal Club invites you to a virtual discussion, Wednesday, Feb. 26, at 5:30 pm ET, on the 1-year results of the TRILUMINATE & TRISCEND II pivotal trials Learn more & register: share.hsforms.com/1uU196vYnSuCuo… #JACCJournals #CathLab Dr. Gilbert Tang Megan Burke, MD @arnoldgehrke

🚨 We’re hiring! …told you to wait for it! Seeking a Director of Cardiovascular Research to lead groundbreaking studies & mentor future clinical scholars. 📍 Kansas City, MO 💡 Leadership, research, & academic impact 🔗 Apply now or share! Saint Luke's Saint Luke's Mid America Heart Institute

Real-world low-risk TAVR outcomes in the USA: 1-year mortality & stroke rates were slightly higher than pivotal trial results from the 3 STS/ACC TVT registry. David J. Cohen, MD, MSc William Fearon Samir Kapadia @arnoldgehrke Vinod Thourani Wayne Batchelor, MD Tsuyoshi Kaneko ahajournals.org/doi/full/10.11…

I am saddened to learn about President Biden’s diagnosis of what seems to be metastatic prostate cancer. However, let’s please get away with the “fighter” metaphor. It’s harmful. This “fight” metaphor leads to excessive and harmful care. And choosing a treatment that prioritizes

Happening now Rock Star Suzanne Arnold presenting late breaker on TriQol clinical study of health status impact of tricuspid interventions Cardiovascular Research Foundation Saint Luke's Mid America Heart Institute

🚨 New paper out in JACC! We examined angina trajectories in the ISCHEMIA trial—how patients’ symptoms evolved over 2 years after an initial invasive vs conservative strategy. jacc.org/doi/10.1016/j.… 👉I’ll summarize the key findings in this thread.

One of the most fun things I did in 2025. I was so excited to be a part of this Case Record of the MGH and the Shared Decision Making Forum. And meeting this patient who lived life to the utmost was a true honor. ❤️ MGH Health Decision Sciences Center

Can we please stop the practice of clapping in the middle of every LBCT? It makes sense for something like COAPT, with so much effort and surprisingly/strikingly positive results. Meeting a NI endpoint with a wide margin shouldn’t cause eruption in applause. Just clap at the end.